NCT02122601View on ClinicalTrials.gov

A Clinical Trial to Evaluate the Safety and Efficacy of Retreatment With Intra-articular LBSA0103 Injections in the Patients With Osteoarthritis of the Knee

PHASE3CompletedINTERVENTIONAL
Enrollment

174

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

May 31, 2015

Study Completion Date

May 31, 2015

Conditions
Osteoarthritis of Knee
Interventions
DRUG

LBSA0103 (BDDE cross-linked sodium hyaluronate gel)

Trial Locations (1)

110-744

Seoul National University Hospital, Seoul

Sponsors

Lead Sponsor

LG Life Sciences
All Listed Sponsors
lead

LG Life Sciences

INDUSTRY

NCT02122601 - A Clinical Trial to Evaluate the Safety and Efficacy of Retreatment With Intra-articular LBSA0103 Injections in the Patients With Osteoarthritis of the Knee | Biotech Hunter | Biotech Hunter